Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maternal methadone dose and neonatal withdrawal.

Vincenzo Berghella1, Pearl J Lim, Mary K Hill

  • 1Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA. vincenzo.berghella@jefferson.edu

American Journal of Obstetrics and Gynecology
|October 2, 2003
PubMed
Summary

Maternal methadone dosage does not correlate with neonatal withdrawal symptoms in infants born to mothers undergoing treatment for heroin addiction. Effective methadone dosing for mothers does not increase neonatal harm.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA/RNA-Based Next-Generation Sequencing Improves the Early Diagnosis and Management of Neoplastic Bile Duct Strictures: A 6-Year, Prospective, Multi-Institutional, Real-Time Study.

Gastroenterology·2026
Same author

PancreaSeq Genomic Classifier (PancreaSeq GC) Improves Pancreatic Cyst Classification and Detection of Advanced Neoplasia: A Multi-institutional Validation Study.

Annals of surgical oncology·2025
Same author

Prevalence of exocrine pancreatic insufficiency at 12 months after acute pancreatitis: a prospective, multicentre, longitudinal cohort study.

EClinicalMedicine·2024
Same author

Natural history of spontaneous pancreatic portal vein fistulae: A systematic review of the literature.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2024
Same author

The Contact Dermatitis Quality of Life Index (CDQL): Survey Development and Content Validity Assessment.

JMIR dermatology·2023
Same author

A Combined DNA/RNA-based Next-Generation Sequencing Platform to Improve the Classification of Pancreatic Cysts and Early Detection of Pancreatic Cancer Arising From Pancreatic Cysts.

Annals of surgery·2023

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Addiction Medicine

Background:

  • Opioid use disorder in pregnancy presents significant risks to both mother and neonate.
  • Methadone maintenance therapy is a cornerstone treatment for opioid use disorder during pregnancy.
  • Understanding the relationship between maternal methadone dosage and neonatal outcomes is crucial for optimizing care.

Purpose of the Study:

  • To investigate the correlation between maternal methadone dosage and the severity of neonatal withdrawal.
  • To assess if higher maternal methadone doses lead to increased neonatal abstinence scores or prolonged withdrawal symptoms.

Main Methods:

  • Retrospective review of 100 maternal/neonatal records for pregnancies maintained on methadone therapy.
  • Objective assessment of neonatal withdrawal using the neonatal abstinence score.

Related Experiment Videos

  • Correlation analysis between average and last maternal methadone doses and neonatal withdrawal measures.

    • Main Results:

    • No significant correlation was found between maternal methadone dosage (average or last dose) and neonatal withdrawal severity.
    • Neonatal abstinence scores, treatment needs, and withdrawal durations were similar across different maternal methadone dosage groups.
    • A trend towards higher illicit drug abuse before delivery was observed in women receiving lower average methadone doses (<80 mg).

    Conclusions:

    • Maternal methadone dosage does not appear to influence the incidence or severity of neonatal withdrawal.
    • The benefits of effective maternal methadone dosing are not offset by increased neonatal harm.
    • This finding supports the use of adequate methadone doses for maternal stability without increased concern for neonatal abstinence syndrome severity.